Published on in Vol 23, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27188, first published .
The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study

The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study

The Utility of Different Data Standards to Document Adverse Drug Event Symptoms and Diagnoses: Mixed Methods Study

Journals

  1. Andrikyan W, Jung-Poppe L, Altenbuchner A, Nicolaus H, Pfistermeister B, Dormann H, Fromm M, Maas R. Documentation of Drug-Related Problems with ICD-11: Application of the New WHO Code-Set to Clinical Routine Data. Journal of Clinical Medicine 2022;12(1):315 View
  2. Cragg A, Small S, Lau E, Rowe A, Lau A, Butcher K, Hohl C. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Safety 2023;46(11):1161 View
  3. Lau E, Cragg A, Small S, Butcher K, Hohl C. Characterizing and Comparing Adverse Drug Events Documented in 2 Spontaneous Reporting Systems in the Lower Mainland of British Columbia, Canada: Retrospective Observational Study. JMIR Human Factors 2024;11:e52495 View
  4. Wernli B, Verloo H, von Gunten A, Pereira F. Using Existing Clinical Data to Measure Older Adult Inpatients’ Frailty at Admission and Discharge: Hospital Patient Register Study. JMIR Aging 2024;7:e54839 View